ADAMTS13 and thrombotic thrombocytopenic purpura: Recombinant ADAMTS13 at doses between 400–1600 U/kg (injected into the rats 15 min after TTP symptoms were triggered) prevented cytopenias and the rise in LDH and reduced microthrombi in organs compared to control rats [74].